Sartorius Stedim Biotech annual revenue
2020
2021
2022
2023
2024
2025
Sartorius Stedim Biotech Revenue Growth & History (DIM)
Sartorius Stedim Biotech reported €2.97B in revenue for fiscal 2025, an increase of 6.74% from the previous fiscal year.
View full Sartorius Stedim Biotech company overviewSartorius Stedim Biotech annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €2.97B | €187.5M | +6.74% |
| 2024 | 2024-12-31 | €2.78B | €4.5M | +0.16% |
| 2023 | 2023-12-31 | €2.78B | −€717.2M | −20.53% |
| 2022 | 2022-12-31 | €3.49B | €605.7M | +20.98% |
| 2021 | 2021-12-31 | €2.89B | €976.9M | +51.15% |
| 2020 | 2020-12-31 | €1.91B | — | — |
Sartorius Stedim Biotech quarterly revenue
Q1.25
Q2.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €765.7M | €20.7M | +2.78% |
| Q1 2026 | 2026-03-31 | €761.5M | €16.9M | +2.27% |
| Q4 2025 | 2025-12-31 | €772.2M | — | — |
| Q2 2025 | 2025-06-30 | €745.0M | — | — |
| Q1 2025 | 2025-03-31 | €744.6M | — | — |
Sartorius Stedim Biotech revenue growth trends
Over the last five reported fiscal years, revenue grew from €1.91B to €2.97B, a compound annual growth rate of 9.21%. Sartorius Stedim Biotech's latest reported quarter, Q2 2026, generated €765.7M in revenue, an increase of 2.78% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Sartorius Stedim Biotech source filings ↗